SCI Abstract

search
New interest in fibrinogen as an ischemic risk factor
New interest in fibrinogen as an ischemic risk factor
Platelet-fibrin clot formation is a key process in acute arterial thrombosis. The relationship between thrombin-induced pl...
Enhanced thrombin generation induced by extracellular vesicles from severe COVID−19 cases
Enhanced thrombin generation induced by extracellular vesicles from severe COVID−19 cases
Authors and AffiliationsUniversity of Sao Paulo Medical School, Sao Paulo, BrazilBárbara Gomes Barion & Thaís Dourado ...
Bleeding outcomes in critically ill patients on heparin with discordant aPTT and anti-Xa activity
Bleeding outcomes in critically ill patients on heparin with discordant aPTT and anti-Xa activity
• Hospitalized patients may exhibit discordance in aPTT and anti-Xa activities while on UFH. • In this study, ...
Discovery of a new lead molecule to develop a novel class of human factor XIIa inhibitors
Discovery of a new lead molecule to develop a novel class of human factor XIIa inhibitors
Factor XIIa (FXIIa) is a plasma serine protease within the contact activation pathway. Inhibiting FXIIa could offer a viab...
Impaired fibrinolysis in patients with atrial fibrillation and elevated circulating lipopolysaccharide
Impaired fibrinolysis in patients with atrial fibrillation and elevated circulating lipopolysaccharide
It is unknown whether elevated gut-derived serum lipopolysaccharide (LPS) can affect thrombin generation, fibrinolysis, an...
Haemostatic gene variations in cervical cancer-associated venous thrombosis: considerations for clinical strategies
Haemostatic gene variations in cervical cancer-associated venous thrombosis: considerations for clinical strategies
Venous thromboembolism (VTE) is a life-threatening haemostatic disease frequently diagnosed among the cancer population. T...
Cerebral venous sinus thrombosis associated with cancer: analysis of the ACTION-CVT study
Cerebral venous sinus thrombosis associated with cancer: analysis of the ACTION-CVT study
Nearly one fifth of patients with venous thromboembolism (VTE) have cancer. When both of these conditions occur, especiall...
ET1 acts as a potential plasma biomarker and therapeutic target in deep venous thrombosis rat model
ET1 acts as a potential plasma biomarker and therapeutic target in deep venous thrombosis rat model
Deep venous thrombosis (DVT) is the third leading cause of death in cardiovascular disease, following heart attacks and st...
Effect of Ultrasound on Thrombus debris during Sonothrombolysis in a Microfluidic device
Effect of Ultrasound on Thrombus debris during Sonothrombolysis in a Microfluidic device
Microbubble-mediated sonothrombolysis has been proven to be a non-invasive and efficient method for thrombolysis. Neverthe...
SARS-CoV-2 spike protein potentiates platelet aggregation via upregulating integrin αIIbβ3 outside-in signaling pathway
SARS-CoV-2 spike protein potentiates platelet aggregation via upregulating integrin αIIbβ3 outside-in signaling pathway
Platelet hyperreactivity is one of the crucial causes of coagulative disorders in patients with COVID-19. Few studies have...
Risk of venous thromboembolism in relation to high physical activity level in men over 27 year follow up
Risk of venous thromboembolism in relation to high physical activity level in men over 27 year follow up
Venous thromboembolism (VTE) is the third most common type of cardiovascular disease. An association between high level of...
Anticoagulant prescribing patterns in patients with primary central nervous system malignancies and secondary metastases
Anticoagulant prescribing patterns in patients with primary central nervous system malignancies and secondary metastases
To evaluate the safety of direct oral anticoagulants (DOACs) versus low-molecular weight heparin (LMWH) in patients with c...